FRCPath Haem Part 1 MCQ-Oncology 252

A 72yr-old pt with R/R DLBCL, has progressed after R-CHOP and CAR-T. Commenced on Epcoritamab. What is the mechanism of action of Epcoritamab?

• Anti-PD-1 monoclonal antibody
• Antibody–drug conjugate targeting CD79b
• Bispecific antibody targeting CD19 and CD3 leading to B-cell
• Bispecific antibody that simultaneously binds CD3 and CD20

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now